Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Transform your budget into a powerful savings tool with these optimization techniques. Improve your financial situation now!
18,983 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
SpaceX's move toward a public market future brings questions about lockups. This guide explains spacex lockup period:...
A director sold 20,000 shares of First Merchants Corp in a move totaling about $835k. This article explains why insid...
Palantir has a unique data platform and government-commercial mix. This guide outlines how the business could evolve,...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
AI is reshaping memory demand, and Micron sits at the center. This long-form guide explains the bull case for micron ...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
When a founder sells a portion of stock, investors often wonder if it signals trouble or opportunity. This deep dive ...
Investors spotted a notable move in the mining space as Coeur Mining stock popped after an earnings beat. This piece ...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
The FTC signals a softer regulatory stance under a Trump administration, even as a new study shows a fifth of America...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...